GlassScriptPhysician profile
April E Cassady
NPI 1710228473
$4,058.58
in general payments reported to CMS, 2019-2025
39 companies · $660 in 2025
The $660 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $764 · 2022: $957 · 2023: $925 · 2024: $753 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,189 · Education: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,189.35 |
| Education | $147.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $841.63 | 2021-2025 | Erleada, Akeega, Carvykti |
| Mallinckrodt Hospital Products INC. | $331.99 | 2022-2025 | Acthar, Terlivaz |
| Astrazeneca Pharmaceuticals LP | $257.34 | 2021-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $254.15 | 2021-2025 | |
| Travere Therapeutics, INC. | $224.06 | 2023-2025 | Filspari |
| Axonics, INC. | $203.28 | 2021-2024 | Axonics |
| Vifor Pharma, INC. | $189.25 | 2021-2023 | Korsuva, Veltassa |
| Sumitomo Pharma America, INC. | $182.53 | 2023-2025 | Gemtesa |
| Ani Pharmaceuticals, INC. | $158.22 | 2025 | Purified Cortrophin Gel |
| Accord Healthcare, INC. | $155.97 | 2022-2025 | |
| Abbvie INC. | $91.75 | 2021-2025 | |
| Urovant Sciences INC | $90.06 | 2022 | |
| Merck Sharp & Dohme LLC | $76.82 | 2023-2024 | Lynparza |
| Blue Earth Diagnostics | $74.92 | 2021-2022 | |
| Pfizer INC. | $72.12 | 2022-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Cassady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.